[Federal Register Volume 83, Number 47 (Friday, March 9, 2018)]
[Notices]
[Pages 10485-10486]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-04741]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-18-18EV]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled Enhanced Surveillance for Histoplasmosis to
the Office of Management and Budget (OMB) for review and approval. CDC
previously published a ``Proposed Data Collection Submitted for Public
Comment and Recommendations'' notice on December 21, 2017 to obtain
comments from the public and affected agencies. CDC did not receive
comments related to the previous notice. This notice serves to allow an
additional 30 days for public and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or send an email to [email protected]. Direct written comments
and/or suggestions regarding the items contained in this notice to the
Attention: CDC Desk Officer, Office of Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by fax to (202) 395-5806. Provide
written comments within 30 days of notice publication.
[[Page 10486]]
Proposed Project
Enhanced Surveillance for Histoplasmosis--New--National Center for
Emerging and Zoonotic Infectious Diseases (NCEZID), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
Histoplasmosis is an infectious disease caused by inhalation of the
environmental fungus Histoplasma capsulatum. Histoplasmosis can range
from asymptomatic or mild illness to severe disseminated disease, and
it is often described as the most common endemic mycosis in North
America. However, much still remains unknown about the epidemiology and
patient burden of histoplasmosis in the United States.
Histoplasmosis is currently reportable in 11 states but is not
nationally notifiable. In June 2016, the Council of State and
Territorial Epidemiologists (CSTE) passed a position statement to
standardize the case definition for histoplasmosis, a first step
towards more consistent surveillance methodology. A recent multistate
analysis of histoplasmosis cases reported to public health during 2011-
2014 also revealed variation in the data elements collected by each
state, limiting inter-state comparability. In addition, data on
possible exposures, underlying medical conditions, symptoms, and
antifungal treatment were only collected in a few states. Furthermore,
no multistate data exists about histoplasmosis cases identified using
the newly-created CSTE case definition.
More detailed data about histoplasmosis cases detected during
routine surveillance are needed to better understand the features of
persons at risk, characterize the effects of histoplasmosis on patients
(e.g., delays in diagnosis, symptom duration, and decreased
productivity), understand patient awareness of histoplasmosis, and
determine its true public health burden. This information will not only
help inform routine surveillance practices, but also guide awareness
efforts and appropriate prevention strategies.
For a period of one year, health department personnel in
participating states will conduct telephone interviews with individuals
reported as histoplasmosis cases and that meet the CSTE case
definition. Health department personnel will record responses on a
standardized form. The form will collect information on demographics,
underlying medical conditions, exposures, symptom type and duration,
healthcare-seeking behaviors, diagnosis, treatment, and outcomes.
This interview activity is consistent with the state's existing
authority to investigate reports of notifiable diseases for routine
surveillance purposes; therefore, formal consent to participate in the
surveillance is not required. However, individuals may choose not to
participate and may choose not to answer any question they do not wish
to answer.
It will take health department personnel approximately 15 minutes
to administer the questionnaire and 15 minutes to retrieve and record
diagnostic information from their state reportable disease database.
For an estimated 300 patient respondents and 10 public health
respondents, this results in an estimated annual burden to the public
of 150 hours. There are no additional costs to respondents other than
their time.
This is a new Information Collection Request. CDC seeks a 24-month
approval. This study is authorized under Section 301 of the Public
Health Service Act (42 U.S.C. 241).
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
Histoplasmosis cases.................. Case Report Form for 300 1 15/60
Histoplasmosis Enhanced
Surveillance.
Health Department Personnel........... Case Report Form for 10 30 15/60
Histoplasmosis Enhanced
Surveillance.
----------------------------------------------------------------------------------------------------------------
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2018-04741 Filed 3-8-18; 8:45 am]
BILLING CODE 4163-18-P